Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation - Summary - MDSpire

Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation

  • By

  • Rose Nakasi

  • Cosmas Wamozo

  • Solomon Nsumba

  • Benjamin Rukundo

  • Tonny Okecha

  • Byron Mubiru

  • Chodrine Mutebi

  • May 11, 2026

  • 0 min

Share

Objective:

To develop an automated histopathological image segmentation solution for cervical cancer lesions using affordable smartphone-assisted microscopy and deep learning, addressing the diagnostic gap in resource-limited settings.

Key Findings:
  • Achieved a mean IoU of 75.8% and a Dice coefficient of 93.1% on validation data, indicating strong segmentation performance.
  • Per-class IoU ranged from 74.13% to 75.41% across 21 feature classes, demonstrating consistent segmentation performance.
  • DeepLabV3+ outperformed U-Net baseline (mIoU: 56.84%, Dice: 68.53%), highlighting the effectiveness of the model architecture.
Interpretation:

The results indicate that smartphone-assisted microscopy combined with DeepLabV3+ can effectively segment cervical cancer lesions, demonstrating potential for improving diagnostic access and patient outcomes in resource-limited settings.

Limitations:
  • Validation results are based on a single institutional dataset, which may limit the generalizability of the findings.
  • Further independent multi-institutional evaluations are needed to assess the model's performance across diverse clinical populations and imaging conditions.
Conclusion:

This study presents a feasible approach to enhance cervical cancer diagnostics in low-resource environments, leveraging affordable technology and advanced deep learning.

Original Source(s)

Related Content